Coeliac Disease in the Nord-Trøndelag Health Study (HUNT)
NCT ID: NCT04041622
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56000 participants
INTERVENTIONAL
2019-06-17
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screen-detected Coeliac Disease, a Population Based Study
NCT01695681
Anti-Tissue Transglutaminase IgA Antibodies
NCT04019223
A Blood Based Diagnostic Test for Coeliac Disease
NCT02442219
Intestinal Transglutaminase Antibodies in Celiac Disease Diagnosis
NCT05810441
HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
NCT01100099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endoscopy and biopsy
Participants of the HUNT study with a positive serological assay for celiac disease are invited to attain a diagnostic endoscopy with duodenal biopsies
Endoscopy and biopsy
Participants with a positive celiac serology are assessed by endoscopy and duodenal biopsy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopy and biopsy
Participants with a positive celiac serology are assessed by endoscopy and duodenal biopsy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Oslo University Hospital
OTHER
Helse Nord-Trøndelag HF
OTHER
University of Groningen
OTHER
Karolinska Institutet
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eivind Ness-Jensen, md phd
Role: PRINCIPAL_INVESTIGATOR
NTNU, Norwegian University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Levanger Hospital, Nord-Trøndelag Hospital Trust
Levanger, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lukina P, Andersen IL, Eggen PT, Mjones PG, Ronne E, Bolstad N, Klaasen RA, Warren DJ, Iversen R, Hveem K, Bernklev T, Jelsness-Jorgensen LP, Pedersen L, Jonkers I, Lagergren P, Sollid LM, Lundin K, Ness-Jensen E. Coeliac disease in the Trondelag Health Study (HUNT), Norway, a population-based cohort of coeliac disease patients. BMJ Open. 2024 Jan 9;14(1):e077131. doi: 10.1136/bmjopen-2023-077131.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/924
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.